Patents by Inventor Massimiliano Corsi

Massimiliano Corsi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for the diagnosis and prognosis of Alzheimer's disease
    Patent number: 9726678
    Abstract: The invention relates to methods of diagnosing Alzheimer's disease (AD) in a subject and methods of determining the prognosis in patients with AD. The adhesion molecules P-selectin and L-selectin are described for the first time for use as biomarkers to aid in the diagnosis of AD. The invention further describes the use of one or more of L-selectin, MCP-1, IL-1?, IL-8 and IFN-? to aid in the prognosis of either accelerated cognitive decline (ACD) or slow cognitive decline (SCD) in patients with AD.
    Type: Grant
    Filed: April 15, 2010
    Date of Patent: August 8, 2017
    Assignee: RANDOX LABORATORIES LTD.
    Inventors: Massimiliano Corsi, Stephen Peter Fitzgerald, John V. Lamont, Paul Innocenzi
  • METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF ALZHEIMER'S DISEASE
    Publication number: 20120142548
    Abstract: The invention relates to methods of diagnosing Alzheimer's disease (AD) in a subject and methods of determining the prognosis in patients with AD. The adhesion molecules P-selectin and L-selectin are described for the first time for use as biomarkers to aid in the diagnosis of AD. The invention further describes the use of one or more of L-selectin, MCP-1, IL-1?, IL-8 and IFN-? to aid in the prognosis of either accelerated cognitive decline (ACD) or slow cognitive decline (SCD) in patients with AD.
    Type: Application
    Filed: April 15, 2010
    Publication date: June 7, 2012
    Applicant: RANDOX LABORATORIES LTD.
    Inventors: Massimiliano Corsi, Stephen P. Fitzgerald, John V. Lamont, Paul Innocenzi